ArticleLeukemia2013

The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry.

E Matutes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.